Inventor · disambiguated record
Madhav N. Devalaraja
Also filed as: DEVALARAJA MADHAV N · DEVALARAJA MADHAV NARASHIMHA
2 granted patents·8 pending applications·2 citations·filing 2016–2024
42Inventor score
Files withNOVO NORDISK AS4MEDIMMUNE LTD2ASTRAZENECA PHARMACEUTICALS LP1CORVIDIA THERAPEUTICS INC1KORRO BIO INC1
Top patents by PatentIndex Score
10 records- 0176US11384143B2Methods for treating IL-6 mediated inflammation without immunosuppressionNOVO NORDISK AS·Filed 2019·Granted Jul 12, 2022·2 cites·12 claims
- 0275US2025129151A1Methods for treating hepcidin-mediated disordersMEDIMMUNE LTD·Filed 2024·Application pending·0 cites
- 0372US2023090473A1Methods for treating il-6 mediated inflammation without immunosuppressionNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 0469US2022227856A1Methods for treating il-6 mediated inflammation without immunosuppressionNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 0559US2021292405A1Methods for treating hepcidin-mediated disordersMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 0658US2019241650A1Methods for treating il-6 mediated inflammation without immunosuppressionCORVIDIA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0757US2025352667A1Methods and compositions for disrupting nrf2-keap1 protein interaction by adar mediated rna editingKORRO BIO INC·Filed 2022·Application pending·0 cites
- 0850US2023287105A1Methods for treating cardiovascular diseaseNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 0944US11203636B2Treatment of existing left ventricular heart failureUNIV YALE·Filed 2018·Granted Dec 21, 2021·0 cites·14 claims
- 1036US2017029499A1Methods for treating hepcidin-mediated disordersASTRAZENECA PHARMACEUTICALS LP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Madhav N. Devalaraja files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →